- Korean War memorial ordered to take down Christian cross
- Billy Graham near death, ‘close to going home to be with the Lord’
- SeaTac, Wash.: City’s new $15 minimum wage heads to court
- Obama mulls support for Islamists in Syria, with conditions
- Obama ‘birther’ theories float, as Hawaii health director killed in crash
- U.S. drone faulted for killing 14 ‘innocent civilians’ at Yemen wedding
- GOP hopes taking shutdown off the table with budget deal will pay dividends
- Chinese Death Star: The moon cited as the perfect launch pad for ballistic missiles
- Help wanted: Homeland Security plagued by vacancies at the top
- We are not amused: Queen’s protection officers warned to keep ‘sticky fingers’ off the royal cashews
FDA clears addiction drug to treat narcotic abuse
The Food and Drug Administration approved the company’s drug Vivitrol as a monthly injection to treat addiction to opioids, highly addictive drugs often abused for their euphoric effects. Vivitrol is already approved for alcoholism.
Shares drugmaker, which is based in Waltham, Mass., jumped 37 cents, or 2.4 percent, to $16.05 in aftermarket trading. The stock had slipped 20 cents to $15.68 during the regular session.
Vivitrol is designed to block brain receptors that deliver the pleasurable sensations associated with alcohol and drug abuse.
The drug was originally approved by the FDA in 2006 to treat alcohol dependence.
Alkermes asked the FDA earlier this year to approve Vivitrol to help patients quit addictions to opioid drugs.
The FDA approved the drug based on company studies that showed patients taking Vivitrol were more likely to be free of opioids than those taking a dummy injection. The typical Vivitrol patient reported opioid-free urine samples 90 percent of the time, compared with 35 percent for those not taking the drug.
“Opioid dependence is a growing disease and we believe that Vivitrol offers physicians and their patients a whole new approach, as the only long-acting, non-addictive treatment for opioid dependence,” Alkermes CEO Richard Pops said.
By Mangosuthu Buthelezi
Memories of a long brotherhood tempered in common struggle
- House budget bargain faces Senate filibuster; Republicans line up to oppose
- Obama's Afghanistan experts stumped on U.S. death toll, war costs during hearing
- Obama birther theories float, as Hawaii health director killed in crash
- NAPOLITANO: A conspiracy so vast
- PRUDEN: The last living witnesses; they wore the yellow star and remember the Nazi terror
- Echoes of Cold War in Ukraine as Russia tries to rein in former Soviet satellites
- KEENE: James Clapper should resign for lying to Congress
- Kim Jong-un consolidating power or losing grip on North Korea's military
- Comma on!: Twitter erupts over Obama-Castro 'marriage'
- Broncos-Chargers game ends with several stabbings
Independent voices from the The Washington Times Communities
Consummate traveler Todd DeFeo explores the unique stories that make destinations worth going to.
Covering the world of soccer, including the World Cup, Major League Soccer, D.C. United and the English Premier League and other interesting sporting events.
Born in 1930 in rural Missouri, Charles Vandegriffe, Sr., brings his time and place to the Communities.
Columns from Voices around the World talking about the events, people, politics and social issues that concern us wherever, and whoever, we are.
Extraordinary day at Redskins Park
White House pets gone wild!
Let it snow